Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial

Faster, Cleaner, Better.

Pdl Biopharma Inc (PDLI)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Cash Flow for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 12/31

(Values in U.S. thousands)

	09-2015	06-2015	03-2015	12-2014	09-2014
Cash Flows From Operating Activities
Net Income	232,221	162,762	84,498	322,244	267,173
Depreciation Amortization	9,773	7,230	4,076	18,562	13,329
Income taxes - deferred	9,143	8,358	3,343	-19,842	-6,493
Accounts receivable	-294	-100	300	N/A	N/A
Accounts payable and accrued liabilities	103	383	297	31	792
Other Working Capital	-1,221	401	-9,210	8,635	15,058
Other Operating Activity	-18,339	-23,134	-11,458	-37,349	-66,620
Operating Cash Flow	$231,386	$155,900	$71,846	$292,281	$223,239

Cash Flows From Investing Activities
Change In Deposits	N/A	-5,226	N/A	N/A	N/A
PPE Investments	-9	N/A	N/A	-49	-49
Purchase Of Investment	N/A	N/A	N/A	-1,750	N/A
Sale Of Investment	1,124	N/A	N/A	3,530	N/A
Purchase Sale Intangibles	-106,030	2,091	938	21,360	66,217
Other Investing Activity	-94,406	2,091	938	-139,840	-148,783
Investing Cash Flow	$-93,291	$-3,135	$938	$-138,109	$-148,832

Cash Flows From Financing Activities
Change In Short Term Borrowing	100,000	100,000	100,000	N/A	N/A
Debt Issued	N/A	N/A	N/A	300,000	300,000
Debt Repayment	-177,387	-177,387	-22,337	-56,191	-29,906
Common Stock Issued	N/A	N/A	N/A	N/A	11,427
Dividend Paid	-73,623	-49,083	-24,549	-96,557	-72,135
Other Financing Activity	-50,607	-25,607	-607	-104,349	-96,488
Financing Cash Flow	$-201,617	$-152,077	$52,507	$42,903	$112,898

Beginning Cash Position	291,377	291,377	291,377	94,302	94,302
End Cash Position	227,855	292,065	416,668	291,377	281,607
Net Cash Flow	$-63,522	$688	$125,291	$197,075	$187,305

Free Cash Flow
Operating Cash Flow	231,386	155,900	71,846	292,281	223,239
Capital Expenditure	-9	N/A	N/A	-49	-49
Free Cash Flow	231,377	155,900	71,846	292,232	223,190